NEWARK, N.Y., July 20, 2017 -- Ultralife Corporation (NASDAQ:ULBI) will report its second quarter results for the period ended July 2, 2017 before the market opens on Thursday, August 3, 2017.
Ultralife’s management will also host an investor conference call and simultaneous webcast at 10:00 AM ET on August 3, 2017. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.
Company Contact: Ultralife Corporation Philip A. Fain (315) 210-6110 [email protected] Investor Relations Contact: LHA Jody Burfening (212) 838-3777 [email protected]


Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Britain Courts Anthropic Amid US Defense Department Dispute
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 



